相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Aberrant regulation of Wnt signaling in hepatocellular carcinoma
Li-Juan Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Teriflunomide for multiple sclerosis
Dian He et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
Hepatocellular carcinoma: Where there is unmet need
Manojkumar Bupathi et al.
MOLECULAR ONCOLOGY (2015)
Leflunomide and teriflunomide: altering the metabolism of pyrimidines for the treatment of autoimmune diseases
Yara Dadalti Fragoso et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2015)
Long noncoding RNAs: a potential novel class of cancer biomarkers
Aliaksandr A. Yarmishyn et al.
FRONTIERS IN GENETICS (2015)
Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells
Ou Huang et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Evolutionary conservation of long non-coding RNAs; sequence, structure, function
Per Johnsson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
Amit Bar-Or et al.
DRUGS (2014)
Leflunomide suppresses growth in human medullary thyroid cancer cells
Amal Alhefdhi et al.
JOURNAL OF SURGICAL RESEARCH (2013)
WNT signalling pathways as therapeutic targets in cancer
Jamie N. Anastas et al.
NATURE REVIEWS CANCER (2013)
Evidence supporting a role for dihydroorotate dehydrogenase, bioenergetics, and p53 in selective teriflunomide-induced apoptosis in transformed versus normal human keratinocytes
Numsen Hail et al.
APOPTOSIS (2012)
Immune mechanisms of new therapeutic strategies in MS - Teriflunomide
Malte C. Claussen et al.
CLINICAL IMMUNOLOGY (2012)
Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity
Kuen-Feng Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Teriflunomide encourages cytostatic and apoptotic effects in premalignant and malignant cutaneous keratinocytes
Numsen Hail et al.
APOPTOSIS (2010)
The role of signaling pathways in the development and treatment of hepatocellular carcinoma
S. Whittaker et al.
ONCOGENE (2010)
Teriflunomide (Leflunomide) Promotes Cytostatic, Antioxidant, and Apoptotic Effects in Transformed Prostate Epithelial Cells: Evidence Supporting a Role for Teriflunomide in Prostate Cancer Chemoprevention
Numsen Hail et al.
NEOPLASIA (2010)
Ubiquitous activation of Ras and Jak/Stat pathways in human HCC
DF Calvisi et al.
GASTROENTEROLOGY (2006)
Leflunomide improves psoriasis in patients with psoriatic arthritis: An in-depth analysis of data from the TOPAS study
P Nash et al.
DERMATOLOGY (2006)
The role of IL-6 and STAT3 in inflammation and cancer
DR Hodge et al.
EUROPEAN JOURNAL OF CANCER (2005)
Leflunomide in the treatment of psoriasis:: results of a phase II open trial
JA Tlacuilo-Parra et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Reduction of the angiogenesis score and tumor growth in subcutaneously implanted colon carcinoma in a mouse model
JW Mall et al.
CHIRURG (2002)
Signaling through the JAK/STAT pathway, recent advances and future challenges
T Kisseleva et al.
GENE (2002)
分享论文
